 Silofexa is a new type of medication called a phansoid exreceptor, FxR, agonist, which has been shown to be safe and effective in treating non-alcoholic steetohepatis, Nash, and primary sclerosing cholangitis, PSE. It works by increasing the amount of bile acids produced by the liver, which helps reduce fatty deposits in the liver.